Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants
SAD18184/MAD18185
Phase 1 other active
Quick answer
Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants for Asthma is a Phase 1 program (other) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Asthma
- Phase
- Phase 1
- Modality
- other
- Status
- active